Human umbilical cord mesenchymal stem cells restore chemotherapy-induced premature ovarian failure by inhibiting ferroptosis in vitro ovarian culture system DOI Creative Commons
Jiaqi Chen,

Zhuoying He,

Wenjuan Xu

et al.

Reproductive Biology and Endocrinology, Journal Year: 2024, Volume and Issue: 22(1)

Published: Nov. 7, 2024

Mesenchymal stem cells (MSCs) have shown potential in repairing chemotherapy-induced premature ovarian failure (POF). However, challenges such as cell loss and immune phagocytosis post-transplantation hinder their application. Due to easy safe handling, vitro culture is widely available for drug screening, pathophysiological research, fertilization. MSCs could exhibit therapeutic capacity injury, avoid tissue system. Therefore, this study utilizes an system investigate the reparative of human umbilical cord mesenchymal (hUCMSCs) mechanism.

Language: Английский

Stem cell-based therapy in cardiac repair after myocardial infarction: Promise, challenges, and future directions DOI Open Access
Wenjun Yan, Yunlong Xia, Huishou Zhao

et al.

Journal of Molecular and Cellular Cardiology, Journal Year: 2024, Volume and Issue: 188, P. 1 - 14

Published: Jan. 20, 2024

Language: Английский

Citations

26

Enhancing mesenchymal stem cell survival and homing capability to improve cell engraftment efficacy for liver diseases DOI Creative Commons
Shaoxiong Yu,

Saihua Yu,

Haiyan Liu

et al.

Stem Cell Research & Therapy, Journal Year: 2023, Volume and Issue: 14(1)

Published: Sept. 4, 2023

Abstract Although mesenchymal stem cell (MSC) transplantation provides an alternative strategy for end-stage liver disease (ESLD), further widespread application of MSC therapy is limited owing to low engraftment efficiency. Improving efficiency plays a critical role in enhancing diseases. In this review, we summarize the current status and challenges ESLD. We also outline complicated cell-homing process highlight how closely related huge differences extracellular conditions involved homing journeys ranging from constant, controlled vitro variable challenging vivo. survival capabilities enhances efficacy. Therefore, strategies, including hypoxic priming, drug pretreatment, gene modification, cytokine as well splenectomy local irradiation, used improve capability, enhance therapeutic therapy. hope that review will provide new insights into

Language: Английский

Citations

30

Heme oxygenase 1-mediated ferroptosis in Kupffer cells initiates liver injury during heat stroke DOI Creative Commons
Ru Li, Riqing Wei,

Chenxin Liu

et al.

Acta Pharmaceutica Sinica B, Journal Year: 2024, Volume and Issue: 14(9), P. 3983 - 4000

Published: May 13, 2024

With the escalating prevalence of global heat waves, stroke has become a prominent health concern, leading to substantial liver damage. Unlike other forms injury, stroke-induced damage is characterized by cytotoxicity and heightened inflammation, directly contributing elevated mortality rates. While clinical assessments have identified bilirubin levels as indicative Kupffer cell dysfunction, their specific correlation with injury remains unclear. Our hypothesis proposes involvement ferroptosis during stroke, initiating IL-1

Language: Английский

Citations

11

Pharmacokinetic characteristics of mesenchymal stem cells in translational challenges DOI Creative Commons
Yunlong Shan, Mengying Zhang,

Enxiang Tao

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2024, Volume and Issue: 9(1)

Published: Sept. 13, 2024

Language: Английский

Citations

11

Bioactive Decellularized Extracellular Matrix Platform Integrating Multifunctional Nanozymes and Cell-Laden Microgels for Acute Liver Failure Treatment DOI
Gang Xiao, Jiabin Zhang,

Tong Lin

et al.

ACS Nano, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 14, 2025

Mesenchymal stem cell (MSC) therapy has emerged as a promising alternative approach for treating acute liver failure (ALF) while confronting the shortage of low efficiency and poor engraftment within hostile milieu. In this study, we establish bioactive decellularized extracellular matrix (dECM) platform that incorporates dihydrolipoic acid (DHLA)-protected Pt nanoclusters doped with Cu (PtCu-DHLA) nanozymes cell-laden microgels. The PtCu-DHLA nanozymes, selected their versatility, function antioxidant, anti-inflammatory, pro-proliferative, pro-angiogenic agents, enhancing ALF alleviation providing an optimal microenvironment MSC transplantation. Additionally, methacrylic anhydride (MA)-modified porcine liver-derived (PLdECM) hydrogel (PLdECMMA) been developed construction microgels via microfluidic devices. Interferon γ (IFNγ) preconditioned MSCs encapsulated in PLdECMMA exhibit enhanced immunomodulating activity prolonged survival. are codelivered by leveraging PLdECM orthotopic transplanted dECM enables efficient successful rescue CCl4-induced counteracting oxidative stress, suppressing inflammatory storms, promoting cellular regeneration. Overall, study highlights synergistic reinforced strategy combines biomimetic therapy, offering significant potential treatment broader applications regenerative medicine.

Language: Английский

Citations

1

Chronic cadmium exposure triggered ferroptosis by perturbing the STEAP3-mediated glutathione redox balance linked to altered metabolomic signatures in humans DOI
Ping Deng,

Jingdian Li,

Yonghui Lu

et al.

The Science of The Total Environment, Journal Year: 2023, Volume and Issue: 905, P. 167039 - 167039

Published: Sept. 15, 2023

Language: Английский

Citations

18

BCAT1 alleviates early brain injury by inhibiting ferroptosis through PI3K/AKT/mTOR/GPX4 pathway after subarachnoid hemorrhage DOI
Nan Liu, Chen Li,

Cong Yan

et al.

Free Radical Biology and Medicine, Journal Year: 2024, Volume and Issue: 222, P. 173 - 186

Published: June 12, 2024

Language: Английский

Citations

6

Suppressing Mesenchymal Stromal Cell Ferroptosis Via Targeting a Metabolism‐Epigenetics Axis Corrects their Poor Retention and Insufficient Healing Benefits in the Injured Liver Milieu DOI Creative Commons
Guangyu Hu, Zhe Cui, Xiyao Chen

et al.

Advanced Science, Journal Year: 2023, Volume and Issue: 10(13)

Published: Feb. 19, 2023

Abstract Mesenchymal stromal cell (MSC) implantation is a promising option for liver repair, but their poor retention in the injured milieu critically blunts therapeutic effects. The aim to clarify mechanisms underlying massive MSC loss post‐implantation and establish corresponding improvement strategies. primarily occurs within initial hours after into or under reactive oxygen species (ROS) stress. Surprisingly, ferroptosis identified as culprit rapid depletion. In ferroptosis‐ ROS‐provoking MSCs, branched‐chain amino acid transaminase‐1 (BCAT1) dramatically decreased, its downregulation renders susceptible via suppressing transcription of glutathione peroxidase‐4 (GPX4), vital defensing enzyme. BCAT1 impedes GPX4 rapid‐responsive metabolism‐epigenetics coordinating mechanism, involving α ‐ketoglutarate accumulation, histone 3 lysine 9 trimethylation loss, early growth response protein‐1 upregulation. Approaches suppress (e.g., incorporating inhibitors injection solvent overexpressing BCAT1) significantly improve liver‐protective effects post‐implantation. This study provides first evidence indicating that excessive nonnegligible depletion insufficient efficacy milieu. Strategies are conducive optimizing MSC‐based therapy.

Language: Английский

Citations

16

Ferroptosis resistance in cancer: recent advances and future perspectives DOI
Zhang Xing, Xiang Li, Xia Ran

et al.

Biochemical Pharmacology, Journal Year: 2023, Volume and Issue: 219, P. 115933 - 115933

Published: Nov. 22, 2023

Language: Английский

Citations

11

Targeting ferroptosis: opportunities and challenges of mesenchymal stem cell therapy for type 1 diabetes mellitus DOI Creative Commons
Le Dai, Qing Wang

Stem Cell Research & Therapy, Journal Year: 2025, Volume and Issue: 16(1)

Published: Feb. 4, 2025

Abstract Type 1 diabetes mellitus (T1DM) is characterized by progressive β-cell death, leading to loss and insufficient insulin secretion. Mesenchymal stem cells (MSCs) transplantation currently one of the most promising methods for replacement therapy. However, recent studies have shown that ferroptosis not only key mechanisms but also reasons extensive cell death within a short period time after MSCs transplantation. Ferroptosis new type regulated (RCD) iron-dependent accumulation lipid peroxides. Due weak antioxidant capacity β-cells, they are susceptible cytotoxic stimuli such as oxidative stress (OS), therefore ferroptosis. Transplanted extremely perturbations in their microenvironment, especially OS, which can weaken induce through In pathophysiological process T1DM, large amount reactive oxygen species (ROS) produced, causing OS. Therefore, targeting may be way protect β-cells improve therapeutic effect This review reviews research related MSCs, summarizes developed strategies help inhibit study aims understand mechanism transplantation, emphasize importance protecting improving survival function transplanted provide direction therapy T1DM future.

Language: Английский

Citations

0